Abstract Interleukin-1 (IL-1) is the prototypical pro-inflammatory cytokine. IL-1 was implicated
as a cardiodepressant factor in septic shock, and subsequent pre-clinical and clinical …

Background: Interleukin-1 (IL-1) is an inflammatory cytokine that responds as an acute
phase reactant during acute myocardial infarction. Conflicting data describe the role of anti …

Background Interleukin‐6 (IL‐6) is an inflammatory cytokine implicated in plaque instability
in acute coronary syndrome (ACS). We aimed to evaluate the prognostic implications of IL‐6 …

Objective To determine whether rapid clearance of interleukin 8 (IL-8) from plasma through
binding to the erythrocyte chemokine receptor may be responsible for failure to detect IL-8 …

The prevalance of congestive heart failure and its continued poor prognosis despite
presently available therapeutic options emphasize the importance of pursuing the …

Background—Experimental interleukin-1 receptor antagonist gene overexpression has
shown that interleukin-1 receptor antagonist is cardioprotective during global cardiac …

Objective: To determine whether the serum concentrations of some circulating cytokines (as
highly sensitive markers of inflammation) are of value in predicting the outcome of patients …

Abstract Purpose Interleukin-1 (IL-1) receptor antagonist (Ra) is a naturally occurring IL-1
blocker with a cardioprotective effect during acute myocardial infarction (AMI). Anakinra …

Abstract purpose and patients: We measured the serum concentrations of interleukin-6 (IL-6)
in 70 patients with established septic shock caused predominantly by gram-negative …

Postarrest myocardial dysfunction includes the development of low cardiac output or
ventricular systolic or diastolic dysfunction after cardiac arrest. Impaired left ventricular …